Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | METAP2 | P50579 | 1/20 | 0.39 |
| ▸ | METAP1 | P53582 | 1/20 | 0.39 |
| ▸ | PI4KA | P42356 | 2/20 | 0.38 |
| ▸ | PI4K2B | Q8TCG2 | 2/20 | 0.38 |
| ▸ | PI4K2A | Q9BTU6 | 2/20 | 0.38 |
| ▸ | PI4KB | Q9UBF8 | 2/20 | 0.38 |
| ▸ | LRRK2 | Q5S007 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.38 |
| ▸ | G6PD | P11413 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 3/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Purine SCHEMBL2120554 | 0.98 | ALDH1A1 (0.47) | ALDH1A1KDM4EMETAP2METAP1PI4KA | |
| Purine SCHEMBL29703771 | 0.98 | ALDH1A1 (0.47) | ALDH1A1KDM4EMETAP2METAP1PI4KA | |
| Purine SCHEMBL6421380 | 0.98 | ALDH1A1 (0.47) | ALDH1A1KDM4EMETAP2METAP1PI4KA | |
| Purine SCHEMBL29365913 | 0.98 | — | — | |
| Purine SCHEMBL3158 | 0.98 | — | — | |
| Purine SCHEMBL30862524 | 0.98 | — | — | |
| Purine SCHEMBL7787140 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4EMETAP2METAP1PI4KA | |
| Purine SCHEMBL31255906 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4EMETAP2METAP1PI4KA | |
| Purine SCHEMBL712798 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4EMETAP2METAP1PI4KA | |
| Purine SCHEMBL6438164 | 0.95 | ALDH1A1 (0.45) | ALDH1A1KDM4EMETAP2METAP1PI4KA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109294976-A | A kind of serum free medium for supporting HEK293 cell suspension cultures | 王晓柯 | 2019-02-01 | — | — | CN | claimed |
| CN-105377238-B | method for treating arthritis | 台湾微脂体股份有限公司 | 2018-09-07 | — | — | CN | claimed |
| CN-107236708-A | A kind of serum free medium for supporting HeLa cell attachment cultures | 王晓柯 | 2017-10-10 | — | — | CN | claimed |
| EP-0304004-B1 | Process for the production of sodium purines | BOEHRINGER INGELHEIM KG (DE) | 1993-11-03 | — | — | EP | claimed |
| WO-2020192302-A1 | PYRIMIDINE-CONTAINING TRI-SUBSTITUTED IMIDAZOLE COMPOUND AND APPLICATION THEREOF | 广州必贝特医药技术有限公司 | 2020-10-01 | — | — | WO | disclosed |
| CN-110352071-A | Lipidic nanoparticles mRNA vaccine | 库瑞瓦格股份公司 | 2019-10-18 | — | — | CN | disclosed |
| CN-109843921-A | Programmed death 1 ligand 1(PD-L1) binding proteins and methods of use thereof | 艾欧凡斯生物治疗公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-109790143-A | Amine-linked C for target protein degradation3-glutarimide solution stator body | C4医药公司 | 2019-05-21 | — | — | CN | disclosed |
| CN-109641874-A | C for target protein degradation3The glutarimide degron body of carbon connection | C4医药公司 | 2019-04-16 | — | — | CN | disclosed |
| CN-109562113-A | Spirocyclo-rongeur for target protein degradation | C4医药公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109562107-A | Heterocyclic degrading ligand for target protein degradation | C4医药公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-109563154-A | Anti- Padua factors IX antibody | 拜科赛尔塔公司 | 2019-04-02 | — | — | CN | disclosed |
| WO-2000064918-A1 | METHOD FOR THE PRODUCTION OF 2-CHLORO-2'-DEOXYADENOSINE (CLADRIBINE) AND ITS 3,5-DI-O-p-TOLUOYL DERIVATIVE | STERRENBELD BIOTECHNOLOGIE NORTH AMERICA, INC. (US) | 2000-11-02 | — | — | WO | disclosed |
| CN-1040114-C | Stereoselective glycosylation process | LILLY CO ELI (US) | 1998-10-07 | — | — | CN | disclosed |
| US-5532225-A | TREATMENT OF HERPES VIRUS | SRI INTERNATIONAL (US) | 1996-07-02 | — | — | US | disclosed |
| CN-1085560-A | Stereoselective glycosylation process | LILLY CO ELI (US) | 1994-04-20 | — | — | CN | disclosed |
| WO-1994003466-A1 | ACYCLIC PURINE PHOSPHONATE NUCLEOTIDE ANALOGS AS ANTIVIRAL AGENTS, AND RELATED SYNTHETIC METHODS | SRI INTERNATIONAL (US) | 1994-02-17 | — | — | WO | disclosed |
| EP-0304004-B1 | Process for the production of sodium purines | BOEHRINGER INGELHEIM KG (DE) | 1993-11-03 | — | — | EP | disclosed |
| EP-0304004-A1 | Process for the production of sodium purines | BOEHRINGER INGELHEIM KG (DE) | 1989-02-22 | — | — | EP | disclosed |
| EP-0304004-A1 | Process for the production of sodium purines | BOEHRINGER INGELHEIM KG (DE) | 1989-02-22 | — | — | EP | disclosed |